معرفی
Dr Christopher Benham is a researcher affiliated with the University of Hertfordshire, specifically the School of Life and Medical Sciences, Department of Clinical, Pharmaceutical and Biological Science. He holds roles in the Centre for Health Services and Clinical Research, Basic and Clinical Science Unit, and the Centre for Research in Mechanisms of Disease and Drug Discovery. With 18 years of experience in pharmaceutical R&D, his research focuses on ion channels (particularly TRP family members) in cardiovascular, sensory, and gastrointestinal systems, emphasizing TRP channel dysfunction in diseases like diabetes. He collaborates with GSK and has led multiple projects, including studies on TRPV1 antagonism in diabetes and ketamine's effects on bladder function.
Research interests encompass drug discovery, ion channel biology, and disease mechanisms. Projects include exploring therapeutic potentials of TRPV1 antagonism, inflammatory responses in pulmonary inflammation, and mechanisms of ketamine-induced bladder hypersensitivity. His work spans pharmacology, neuroscience, and cardiovascular health, with publications on topics like endothelial dysfunction in diabetes and chalcone anti-mycobacterial compounds.
Dr Benham has supervised research projects and contributed to collaborative initiatives, such as studies on innervated trigeminal neurons with GSK. His academic contributions include over 100 research outputs since 1983, with recent focus on TRPV4 channels and diabetic complications. No awards are explicitly mentioned, but his work reflects sustained engagement in translational research and industry-academia partnerships.
